文献速递鼻科

体重指数对内镜鼻窦手术后长期结局的影响

Effect of Body Mass Index on Long-Term Outcomes After Endoscopic Sinus Surgery.
PubMed 文献 · Laryngoscope · 2026-08-03

本研究为纵向队列研究,纳入664例接受内镜鼻窦手术的成人慢性鼻窦炎患者并随访5年。肥胖患者基线SNOT-22评分更高,术后症状随时间加重更快,且翻修手术风险增加,尤其伴鼻息肉者;术前BMI与后续生物制剂使用无关。

要点

  • 肥胖患者基线SNOT-22更高(β=6.70),但差异未达MCID。
  • 肥胖患者术后症状进展更快,每年增加0.82分,第3年累积差异超MCID。
  • 肥胖增加翻修手术风险(HR=2.41),伴鼻息肉者风险更高(HR=5.30)。

核心结论

  • 升高的BMI与更差的基线症状、术后症状进行性恶化及翻修风险增加相关。
  • 尽管基线SNOT-22差异低于MCID,但纵向累积差异到第3年超过MCID。
  • BMI应纳入术前咨询和术后监测的考量。

研究设计与样本

  • 在三级医疗中心开展的纵向队列研究,纳入664例接受内镜鼻窦手术的成人慢性鼻窦炎患者,随访5年。
  • 术前BMI分为正常体重(<25.0 kg/m2)、超重(25.0-29.9)和肥胖(≥30.0)。
  • 结局包括基线SNOT-22评分、纵向SNOT-22轨迹(多变量线性混合效应模型)及翻修手术或生物制剂使用时间(多变量Cox回归)。

主要发现

  • 664例患者中,正常体重占35.4%,超重占35.5%,肥胖占29.1%。
  • 肥胖患者基线SNOT-22评分显著更高(β=6.70;95% CI,2.56-10.85)。
  • BMI与时间交互作用显著(p=0.033),肥胖患者症状每年增加0.82分,较正常体重患者恶化更快。
  • 升高的BMI预测更高的翻修手术风险(HR=2.41;95% CI,1.11-5.22),尤其在鼻息肉患者中(HR=5.30;95% CI,1.45-19.35)。
  • 术前BMI与后续生物制剂使用无关(HR=1.67;95% CI,0.64-4.36)。

关键数值与推荐

  • 肥胖定义为BMI ≥30.0 kg/m2,超重为25.0-29.9 kg/m2,正常体重为<25.0 kg/m2。
  • 基线SNOT-22差异(β=6.70)低于MCID,但纵向累积差异到第3年超过MCID。

临床怎么用

  • 对于接受内镜鼻窦手术的慢性鼻窦炎患者,术前应评估BMI以进行风险分层和咨询。
  • 肥胖患者术后症状可能进行性加重,需加强长期监测。
  • 伴鼻息肉的肥胖患者翻修手术风险显著增高,应个性化制定随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Whether body mass index (BMI) influences long-term clinical outcomes after endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) remains unclear. We investigated whether BMI is associated with baseline symptom severity, longitudinal postoperative symptom trajectories, and time to revision surgery or biologic use. METHODS: We conducted a longitudinal cohort study of adult CRS patients undergoing ESS at a tertiary care center with 5-year follow-up. Preoperative BMI was categorized as normal weight (< 25.0 kg/m2), overweight (25.0-29.9), and obese (≥ 30.0). Outcomes were baseline 22-item Sinonasal Outcome Test (SNOT-22) scores, longitudinal SNOT-22 trajectories analyzed via multivariable linear mixed-effects models, and time to revision surgery or biologic use via multivariable Cox regression. RESULTS: Among 664 patients, 35.4% were normal weight, 35.5% overweight, and 29.1% obese. Obese patients had significantly higher baseline SNOT-22 scores (β, 6.70; 95% CI, 2.56-10.85). A significant BMI-by-time interaction (p = 0.033) revealed that obese patients' symptoms worsened at a greater rate over time, increasing by 0.82 points per year versus normal-weight patients. Elevated BMI predicted higher revision surgery risk (hazard ratio [HR], 2.41; 95% CI, 1.11-5.22), particularly in patients with nasal polyps (HR, 5.30; 95% CI, 1.45-19.35). Preoperative BMI was not associated with subsequent biologic use (HR, 1.67; 95% CI, 0.64-4.36). CONCLUSION: Elevated BMI was associated with worse baseline symptoms, progressive postoperative symptom deterioration, and increased revision risk. Although baseline SNOT-22 differences were below the minimal clinically important difference (MCID), cumulative longitudinal divergence exceeded the MCID by year 3, indicating that BMI should inform preoperative counseling and postoperative monitoring.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Ghannam JY, Zhou AS, Gray ST, et al. Effect of Body Mass Index on Long-Term Outcomes After Endoscopic Sinus Surgery. Laryngoscope. 2026. PMID: 42547224. doi:10.1002/lary.70788

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。